DiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Leukemia, Hairy CellPentostatinMedication ErrorsMedication AdherenceArabinonucleosidesLeukemia, Lymphocytic, Chronic, B-CellAminosalicylic AcidsVidarabineAntineoplastic AgentsRemission InductionMedication ReconciliationMedication SystemsLeukemia, ProlymphocyticMedication Systems, HospitalDrug Administration ScheduleChlorambucilTreatment OutcomeWaldenstrom MacroglobulinemiaPolandSplenectomy2-ChloroadenosineInfusions, IntravenousRetreatmentPrescription DrugsSelf MedicationAntibodies, Monoclonal, Murine-DerivedDrug PrescriptionsPolypharmacyPatient ComplianceDrug TherapyAntineoplastic Combined Chemotherapy ProtocolsRecurrencePsychotropic DrugsAdenine NucleotidesBenzenesulfonatesDrug Screening Assays, AntitumorDaunorubicinImmunosuppressive AgentsCyclophosphamideAdministration, OralAntipsychotic AgentsFollow-Up StudiesLymphoma, Non-HodgkinPrednisoneRetrospective StudiesNonprescription DrugsDrug UtilizationSurvival RateNeoplasm, ResidualCladribineCytarabineNeutropeniaAntihypertensive AgentsDrug-Related Side Effects and Adverse ReactionsProspective StudiesPharmacistsClinical Pharmacy Information SystemsInhibitory Concentration 50Lymphoma, B-CellUnited StatesPharmaceutical PreparationsThrombocytopeniaTreatment FailureLeukemia, Myeloid, AcuteAntidepressive AgentsMedical Order Entry SystemsDrug Therapy, Computer-AssistedInterferonsInjections, SubcutaneousDrug Resistance, NeoplasmElectronic PrescribingNeoplasms, Second PrimaryDrug CostsInsurance, Pharmaceutical ServicesDose-Response Relationship, DrugAnti-Asthmatic AgentsDisease-Free SurvivalPharmaceutical ServicesPharmacy Service, HospitalVincristineCross-Sectional StudiesPhysician's Practice PatternsQuestionnairesRisk FactorsDrug LabelingInappropriate PrescribingDisease ProgressionCommunity Pharmacy ServicesTreatment RefusalPrescription FeesDrug MonitoringCohort StudiesPatient Education as TopicApoptosisPharmaciesCentral Nervous System StimulantsDrug Information ServicesHypertensionAsthmaDouble-Blind Method